Johannes Zacherl

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Ramucirumab plus paclitaxel or FOLFIRI in platinum-refractory advanced or metastatic gastric or gastroesophageal junction adenocarcinoma-experience at two centres.

Ramucirumab plus paclitaxel or FOLFIRI in platinum-refractory advanced or metastatic gastric or gastroesophageal junction adenocarcinoma-experience at two centres.

Journal: Journal of gastrointestinal oncology

Published: May 14, 2020

Lumen-apposing metal stent creating jejuno-jejunostomy for blind pouch syndrome in patients with esophago-jejunostomy after gastrectomy: a novel technique.

Lumen-apposing metal stent creating jejuno-jejunostomy for blind pouch syndrome in patients with esophago-jejunostomy after gastrectomy: a novel technique.

Journal: Endoscopy

Published: August 22, 2019

Complications of central venous port systems: a pictorial review.

Complications of central venous port systems: a pictorial review.

Journal: Insights into imaging

Published: January 30, 2019

Morbidity in open versus minimally invasive hybrid esophagectomy (MIOMIE): Long-term results of a randomized controlled clinical study.

Morbidity in open versus minimally invasive hybrid esophagectomy (MIOMIE): Long-term results of a randomized controlled clinical study.

Journal: European surgery : ACA : Acta chirurgica Austriaca

Published: July 04, 2018

• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.

• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.

Journal: European surgery : ACA : Acta chirurgica Austriaca

Published: April 05, 2018

Quality of Life after Hernia Surgery.

Quality of Life after Hernia Surgery.

Journal: Hernia : the journal of hernias and abdominal wall surgery

Published: November 01, 2015

Lateral Fasciectomy Sparing the Superficial Peroneal Nerve with Simultaneous Mesh Graft in Non-healing Lateral Leg Ulcers of Diverse Vascular Origins: Surgical Technique, Short- and Long-term Results from 44 Legs.

Lateral Fasciectomy Sparing the Superficial Peroneal Nerve with Simultaneous Mesh Graft in Non-healing Lateral Leg Ulcers of Diverse Vascular Origins: Surgical Technique, Short- and Long-term Results from 44 Legs.

Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

Published: July 14, 2015

The current evidence in support of multimodal treatment of locally advanced, potentially resectable esophageal cancer.

The current evidence in support of multimodal treatment of locally advanced, potentially resectable esophageal cancer.

Journal: Digestive diseases (Basel, Switzerland)

Published: March 08, 2014

Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial.

Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial.

Journal: Surgical endoscopy

Published: January 29, 2014

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.

Journal: The Journal of thoracic and cardiovascular surgery

Published: September 05, 2013

Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract.

Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract.

Journal: Anticancer research

Published: July 31, 2013

The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.

The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.

Journal: Anticancer research

Published: May 07, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026